Vital Living, the US-based nutraceutical producer, has applied for a listing of its common stock on the American Stock Exchange.
Brad Edson, Vital Living's CEO, said: "A listing on the American Stock Exchange should allow for significantly enhanced retail and institutional coverage of our company, which we anticipate will result in a greater shareholder value.
"This move, coupled with our recently completed private placement of over $3.7 million, should position the company nicely to execute and expand on its current contracts with major medical institutions."
Vital Living manufactures specialised medical foods and nutraceuticals for distribution through physicians. Its first product, a specialised medical food supplement for cardiovascular patients, will begin distribution at the Arizona Heart Institute (AHI) later this year.
The company is also developing and testing other nutraceutical products in collaboration with leading medical experts. At present its focus is on cardio vascular health, but products designed to treat ailments in other areas are also planned.